Merck to Hold Investor Briefing at 2016 ASCO Annual Meeting

Industry Reports

Merck known as MSD outside the United States and Canada, announced that Dr. Roger M. Perlmutter, president, Merck Research Laboratories, will present an overview of the company’s oncology program at the 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago on June 6, 2016 at 5:45 p.m. CDT (6:45 p.m. EDT).

Investors, analysts, members of the media and the general public are invited to listen to a live audio webcast of the presentation at or by dialing (866) 486-2604 and using ID code number 21794108.

About Merck
For 125 years, Merck has been a global health care leader working to help the world be well. Merck is known as MSD outside the United States and Canada. Through our prescription medicines, vaccines, biologic therapies, and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. For more information, visit and connect with us on Twitter, Facebook, YouTube and LinkedIn. You can also follow our Twitter conversation at $MRK.

Contact: Merck Media:
Lainie Keller, (908) 236-5036

Teri Loxam, (908) 740-1986
Justin Holko, (908) 740-1879

Subscribe to our Newsletter
Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.
More information Ok